SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-011423
Filing Date
2024-04-08
Accepted
2024-04-08 17:14:27
Documents
15
Period of Report
2024-04-08
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20240404_8k.htm   iXBRL 8-K 23035
6 mbrx20240404_8kimg001.jpg GRAPHIC 3331
  Complete submission text file 0001437749-24-011423.txt   163321

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20240408.xsd EX-101.SCH 3408
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20240408_def.xml EX-101.DEF 11423
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20240408_lab.xml EX-101.LAB 15309
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20240408_pre.xml EX-101.PRE 11583
18 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20240404_8k_htm.xml XML 2834
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671997 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 24830441
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)